{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:49:59Z","timestamp":1786974599661,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T00:00:00Z","timestamp":1623542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["11805104"],"award-info":[{"award-number":["11805104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82003532"],"award-info":[{"award-number":["82003532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Provincial Key Research and Development Special Fund","award":["BE2017612"],"award-info":[{"award-number":["BE2017612"]}]},{"name":"Nanjing Medical Foundation","award":["ZKX17027"],"award-info":[{"award-number":["ZKX17027"]}]},{"name":"Health Commission of Jiangsu Province","award":["H2019091"],"award-info":[{"award-number":["H2019091"]}]},{"name":"Nanjing Medical and Health International Joint Research and Development Project","award":["201911042"],"award-info":[{"award-number":["201911042"]}]},{"name":"The Second Round Fund of Nanjing Clinical Medical Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) are beneficial in patients with lung cancer. We explored the clinical value of [<jats:sup>99m<\/jats:sup>Tc]Tc-Galacto-RGD<jats:sub>2<\/jats:sub> single-photon emission computed tomography (SPECT\/CT) in patients with lung cancer, integrin \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> expression, and neovascularization in lung cancer subtypes was also addressed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 185 patients with lung cancer and 25 patients with benign lung diseases were enrolled in this prospective study from January 2013 to December 2016. All patients underwent [<jats:sup>99m<\/jats:sup>Tc]Tc-Galacto-RGD<jats:sub>2<\/jats:sub> imaging. The region of interest was drawn around each primary lesion, and tumour uptake of [<jats:sup>99m<\/jats:sup>Tc]Tc-Galacto-RGD<jats:sub>2<\/jats:sub> was expressed as the tumour\/normal tissue ratio(T\/N). The diagnostic efficacy was evaluated by receiver operating characteristic curve analysis. Tumour specimens were obtained from 66 patients with malignant diseases and 7 with benign disease. Tumour expression levels of \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub>, CD31, Ki-67, and CXCR4 were further analysed for the evaluation of biological behaviours.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The lung cancer patients included 22 cases of small cell lung cancer (SCLC), 48 squamous cell carcinoma (LSC), 97 adenocarcinoma (LAC), and 18 other types of lung cancer. The sensitivity, specificity, and accuracy of [<jats:sup>99m<\/jats:sup>Tc]Tc-Galacto-RGD<jats:sub>2<\/jats:sub> SPECT\/CT using a cut-off value of T\/N ratio at 2.5 were 91.89%, 48.0%, and 86.67%, respectively. Integrin \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> expression was higher in non-SCLC compared with SCLC, while LSC showed denser neovascularization and higher integrin \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> expression. Integrin \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> expression levels were significantly higher in advanced (III, IV) than early stages (I, II). However, there was no significant correlation between tumour uptake and \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>[<jats:sup>99m<\/jats:sup>Tc]Tc-Galacto-RGD<jats:sub>2<\/jats:sub> SPECT\/CT has high sensitivity but limited specificity for detecting primary lung cancer, integrin expression in the tumour vessel and tumour cell membrane contributes to the tumour uptake.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-021-00801-x","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T21:02:27Z","timestamp":1623618147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["[99mTc]Tc-Galacto-RGD2 integrin \u03b1v\u03b23-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data"],"prefix":"10.1186","volume":"11","author":[{"given":"Jingjing","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingle","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1089-3095","authenticated-orcid":false,"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,13]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"key":"801_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2019.10.009","volume":"468","author":"D Yang","year":"2020","unstructured":"Yang D, Liu Y, Bai C, Wang X, Powell CA. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 2020;468:82\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2019.10.009.","journal-title":"Cancer Lett"},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1046\/j.1440-1843.2003.00433.x","volume":"8","author":"H Zhang","year":"2003","unstructured":"Zhang H, Cai B. The impact of tobacco on lung health in China. Respirology. 2003;8:17\u201321. https:\/\/doi.org\/10.1046\/j.1440-1843.2003.00433.x.","journal-title":"Respirology"},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322:764\u201374. https:\/\/doi.org\/10.1001\/jama.2019.11058.","journal-title":"JAMA"},{"key":"801_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10:1243\u201360. https:\/\/doi.org\/10.1097\/JTO.0000000000000630.","journal-title":"J Thorac Oncol"},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd.2018.21","volume":"17","author":"FM Ferguson","year":"2018","unstructured":"Ferguson FM, Gray NS. Kinase inhibitors: the road ahead. Nat Rev Drug Discov. 2018;17:353\u201377. https:\/\/doi.org\/10.1038\/nrd.2018.21.","journal-title":"Nat Rev Drug Discov"},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.semcancer.2009.05.003","volume":"19","author":"V Baeriswyl","year":"2009","unstructured":"Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis. Semin Cancer Biol. 2009;19:329\u201337. https:\/\/doi.org\/10.1016\/j.semcancer.2009.05.003.","journal-title":"Semin Cancer Biol"},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ncb2770","volume":"15","author":"R Zaidel-Bar","year":"2013","unstructured":"Zaidel-Bar R. Job-splitting among integrins. Nat Cell Biol. 2013;15:575\u20137. https:\/\/doi.org\/10.1038\/ncb2770.","journal-title":"Nat Cell Biol"},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/cr.2017.108","volume":"27","author":"D Wu","year":"2017","unstructured":"Wu D, Xu Y, Ding T, Zu Y, Yang C, Yu L. Pairing of integrins with ECM proteins determines migrasome formation. Cell Res. 2017;27:1397\u2013400. https:\/\/doi.org\/10.1038\/cr.2017.108.","journal-title":"Cell Res"},{"key":"801_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1126\/science.2821619","volume":"238","author":"E Ruoslahti","year":"1987","unstructured":"Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 1987;238:491\u20137. https:\/\/doi.org\/10.1126\/science.2821619.","journal-title":"Science"},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7150\/thno\/v01p0030","volume":"1","author":"G Niu","year":"2011","unstructured":"Niu G, Chen X. Why integrin as a primary target for imaging and therapy. Theranostics. 2011;1:30\u201347. https:\/\/doi.org\/10.7150\/thno\/v01p0030.","journal-title":"Theranostics"},{"key":"801_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2016.07.008","volume":"42","author":"F Demircioglu","year":"2016","unstructured":"Demircioglu F, Hodivala-Dilke K. alphavbeta3 Integrin and tumour blood vessels-learning from the past to shape the future. Curr Opin Cell Biol. 2016;42:121\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2016.07.008.","journal-title":"Curr Opin Cell Biol"},{"key":"801_CR14","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s00259-014-2702-1","volume":"41","author":"X Sun","year":"2014","unstructured":"Sun X, Ma T, Liu H, Yu X, Wu Y, Shi J, et al. Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin alphavbeta3 and vascular endothelial growth factor. Eur J Nucl Med Mol Imaging. 2014;41:1428\u201339. https:\/\/doi.org\/10.1007\/s00259-014-2702-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/ijc.20681","volume":"113","author":"JM Joseph","year":"2005","unstructured":"Joseph JM, Gross N, Lassau N, Rouffiac V, Opolon P, Laudani L, et al. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts. Int J Cancer. 2005;113:881\u201390. https:\/\/doi.org\/10.1002\/ijc.20681.","journal-title":"Int J Cancer"},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1083\/jcb.201410123","volume":"208","author":"W Zou","year":"2015","unstructured":"Zou W, Teitelbaum SL. Absence of Dap12 and the alphavbeta3 integrin causes severe osteopetrosis. J Cell Biol. 2015;208:125\u201336. https:\/\/doi.org\/10.1083\/jcb.201410123.","journal-title":"J Cell Biol"},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"12587","DOI":"10.1021\/acs.analchem.9b03725","volume":"91","author":"L Zhang","year":"2019","unstructured":"Zhang L, Meng X, Shan X, Gu T, Zhang J, Feng S, et al. Integrin alphavbeta3-specific hydrocyanine for cooperative targeting of glioblastoma with high sensitivity and specificity. Anal Chem. 2019;91:12587\u201395. https:\/\/doi.org\/10.1021\/acs.analchem.9b03725.","journal-title":"Anal Chem"},{"key":"801_CR18","doi-asserted-by":"publisher","first-page":"18224","DOI":"10.1039\/c9nr01105f","volume":"11","author":"T Wang","year":"2019","unstructured":"Wang T, Li G, Wang D, Li F, Men D, Hu T, et al. Quantitative profiling of integrin alphavbeta3 on single cells with quantum dot labeling to reveal the phenotypic heterogeneity of glioblastoma. Nanoscale. 2019;11:18224\u201331. https:\/\/doi.org\/10.1039\/c9nr01105f.","journal-title":"Nanoscale"},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.08.044","volume":"355","author":"FH Wu","year":"2014","unstructured":"Wu FH, Luo LQ, Liu Y, Zhan QX, Luo C, Luo J, et al. Cyclin D1b splice variant promotes alphavbeta3-mediated adhesion and invasive migration of breast cancer cells. Cancer Lett. 2014;355:159\u201367. https:\/\/doi.org\/10.1016\/j.canlet.2014.08.044.","journal-title":"Cancer Lett"},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.matbio.2018.08.004","volume":"77","author":"SR Krishn","year":"2019","unstructured":"Krishn SR, Singh A, Bowler N, Duffy AN, Friedman A, Fedele C, et al. Prostate cancer sheds the alphavbeta3 integrin in vivo through exosomes. Matrix Biol. 2019;77:41\u201357. https:\/\/doi.org\/10.1016\/j.matbio.2018.08.004.","journal-title":"Matrix Biol"},{"key":"801_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10967-015-3928-5","volume":"304","author":"B Yan","year":"2015","unstructured":"Yan B, Qiu F, Ren L, Dai H, Fang W, Zhu H, et al. (99m)Tc-3P-RGD2 molecular imaging targeting integrin alphavbeta3 in head and neck squamous cancer xenograft. J Radioanal Nucl Chem. 2015;304:1171\u20137. https:\/\/doi.org\/10.1007\/s10967-015-3928-5.","journal-title":"J Radioanal Nucl Chem"},{"key":"801_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13019-020-01271-3","volume":"15","author":"R Luo","year":"2020","unstructured":"Luo R, Jiang Y, Huang Y, Chen X, Wang F. Longitudinal observation of solitary fibrous tumor translation into malignant pulmonary artery intimal sarcoma. J Cardiothorac Surg. 2020;15:233. https:\/\/doi.org\/10.1186\/s13019-020-01271-3.","journal-title":"J Cardiothorac Surg"},{"key":"801_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012441","volume":"97","author":"B Yan","year":"2018","unstructured":"Yan B, Fu T, Liu Y, Wei W, Dai H, Fang W, et al. 99mTc-3PRGD2 single-photon emission computed tomography\/computed tomography for the diagnosis of choroidal melanoma: a preliminary STROBE-compliant observational study. Medicine (Baltimore). 2018;97: e12441. https:\/\/doi.org\/10.1097\/MD.0000000000012441.","journal-title":"Medicine (Baltimore)"},{"key":"801_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/cbr.2014.1622","volume":"29","author":"T Fu","year":"2014","unstructured":"Fu T, Qu W, Qiu F, Li Y, Shao G, Tian W, et al. (99m)Tc-3P-RGD2 micro-single-photon emission computed tomography\/computed tomography provides a rational basis for integrin alphavbeta3-targeted therapy. Cancer Biother Radiopharm. 2014;29:351\u20138. https:\/\/doi.org\/10.1089\/cbr.2014.1622.","journal-title":"Cancer Biother Radiopharm"},{"key":"801_CR25","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1021\/mp400085d","volume":"10","author":"S Ji","year":"2013","unstructured":"Ji S, Czerwinski A, Zhou Y, Shao G, Valenzuela F, Sowinski P, et al. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging. Mol Pharm. 2013;10:3304\u201314. https:\/\/doi.org\/10.1021\/mp400085d.","journal-title":"Mol Pharm"},{"key":"801_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4329\/wjr.v9.i6.269","volume":"9","author":"FU Kay","year":"2017","unstructured":"Kay FU, Kandathil A, Batra K, Saboo SS, Abbara S, Rajiah P. Revisions to the tumor, node, metastasis staging of lung cancer (8 (th) edition): rationale, radiologic findings and clinical implications. World J Radiol. 2017;9:269\u201379. https:\/\/doi.org\/10.4329\/wjr.v9.i6.269.","journal-title":"World J Radiol"},{"key":"801_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nucmedbio.2020.06.006","volume":"88\u201389","author":"Q Xu","year":"2020","unstructured":"Xu Q, Liu R, Wang J, Huang Y, Li S, Zhang L, et al. Role of [(99m)Tc]Tc-Galacto-RGD2 SPECT\/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy. Nucl Med Biol. 2020;88\u201389:34\u201343. https:\/\/doi.org\/10.1016\/j.nucmedbio.2020.06.006.","journal-title":"Nucl Med Biol"},{"key":"801_CR28","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","volume":"34","author":"E Hoster","year":"2016","unstructured":"Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, et al. Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the european mantle cell lymphoma network. J Clin Oncol. 2016;34:1386\u201394. https:\/\/doi.org\/10.1200\/JCO.2015.63.8387.","journal-title":"J Clin Oncol"},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ijrobp.2013.02.036","volume":"86","author":"FH Chen","year":"2013","unstructured":"Chen FH, Fu SY, Yang YC, Wang CC, Chiang CS, Hong JH. Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1\/CXCR4 pathway. Int J Radiat Oncol Biol Phys. 2013;86:777\u201384. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.036.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/cncr.24281","volume":"115","author":"S Iwakiri","year":"2009","unstructured":"Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, et al. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer. 2009;115:2580\u201393. https:\/\/doi.org\/10.1002\/cncr.24281.","journal-title":"Cancer"},{"key":"801_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0329-1","author":"IE Demir","year":"2020","unstructured":"Demir IE, Mota RC. Chemokines: the (un)usual suspects in pancreatic cancer neural invasion. Nat Rev Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1038\/s41575-020-0329-1.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","volume":"527","author":"D Peng","year":"2015","unstructured":"Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 2015;527:249\u201353. https:\/\/doi.org\/10.1038\/nature15520.","journal-title":"Nature"},{"key":"801_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41556-020-0465-4","volume":"22","author":"S Lau","year":"2020","unstructured":"Lau S, Feitzinger A, Venkiteswaran G, Wang J, Lewellis SW, Koplinski CA, et al. A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration. Nat Cell Biol. 2020;22:266\u201373. https:\/\/doi.org\/10.1038\/s41556-020-0465-4.","journal-title":"Nat Cell Biol"},{"key":"801_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1021\/acs.molpharmaceut.0c00785","volume":"18","author":"D Kwon","year":"2021","unstructured":"Kwon D, Lozada J, Zhang Z, Zeisler J, Poon R, Zhang C, et al. High-contrast CXCR4-targeted (18)F-PET imaging using a potent and selective antagonist. Mol Pharm. 2021;18:187\u201397. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00785.","journal-title":"Mol Pharm"},{"key":"801_CR35","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1158\/1078-0432.CCR-05-0014","volume":"11","author":"N Cabioglu","year":"2005","unstructured":"Cabioglu N, Yazici MS, Arun B, Broglio KR, Hortobagyi GN, Price JE, et al. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res. 2005;11:5686\u201393. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0014.","journal-title":"Clin Cancer Res"},{"key":"801_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jcmg.2013.12.003","volume":"7","author":"AJ Beer","year":"2014","unstructured":"Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, et al. PET\/CT imaging of integrin alphavbeta3 expression in human carotid atherosclerosis. JACC Cardiovasc Imaging. 2014;7:178\u201387. https:\/\/doi.org\/10.1016\/j.jcmg.2013.12.003.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-021-00801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-021-00801-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-021-00801-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T21:08:57Z","timestamp":1623618537000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-021-00801-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1186\/s13550-021-00801-x","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,13]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were carried out in accordance with the ethical standards of the Nanjing Medical University and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients signed written consent prior to inclusion and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}